CDB-4124 does not cause apoptosis in cultured fibroid cells

Reproductive Sciences

Volumn 18, Issue 9, 2011, Pages 850-857

  Roeder, Hilary ^a   Jayes, Friederike ^a   Feng, Liping ^a   Leppert, Phyllis C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; cleaved caspase 3; selective progesterone receptor modulators; TUNEL; uterine fibroids

Indexed keywords

CASPASE 3; DACTINOMYCIN; STAUROSPORINE; TELAPRISTONE ACETATE;

APOPTOSIS; ARTICLE; BINDING KINETICS; CELL CULTURE; CELL IMMORTALIZATION; CELL LYSATE; COMPUTER PROGRAM; CONTROLLED STUDY; CULTURE MEDIUM; EXTRACELLULAR MATRIX; FLUORESCENCE; FLUORESCENCE MICROSCOPE; IMAGE ANALYSIS; NICK END LABELING; PRIORITY JOURNAL; WESTERN BLOTTING;

APOPTOSIS; CELL LINE; FEMALE; HUMANS; IN SITU NICK-END LABELING; LEIOMYOMA; NORPREGNADIENES; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 80051988006     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111399929     Document Type: Article

References (32)

1. Leppert PC, Baginski T, Prupas C, Catherino WH, Pletcher S, Segars JH. Comparative ultrastructure of collagen fibrils in uterine leiomyomas and normal myometrium. Fertil Steril. 2004 ; 82 (3). 1182-1187 (Pubitemid 39335936)
2. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 ; 188 (1). 100-107 (Pubitemid 36135604)
3. Friedman AJ, Harrison-Atlas D, Barbieri RL, Benacerraf B, Gleason R, Schiff I. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril. 1989 ; 51 (2). 251-256 (Pubitemid 19050523)
4. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect. 2000 ; 108 (suppl 5). 791-793
5. Carr BR, Marshburn PB, Weatherall PT, et al. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab. 1993 ; 76 (5). 1217-1223 (Pubitemid 23155439)
6. Pintiaux A, Chabbert-Buffet N, Foidart JM. Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators. Gynecol Endocrinol. 2009 ; 25 (2). 67-73
7. Engman M, Granberg S, Williams AR, Meng CX, Lalitkumar PG, Gemzell-Danielsson K. Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial. Hum Reprod. 2009 ; 24 (8). 1870-1879
8. Chwalisz K, Larsen L, Mattia-Goldberg C, Edmonds A, Elger W, Winkel CA. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril. 2007 ; 87 (6). 1399-1412 (Pubitemid 46829155)
9. Chen W, Ohara N, Wang J, et al. A novel selective progesterone receptor modulator asoprisnil (J867) inhibits proliferation and induces apoptosis in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab. 2006 ; 91 (4). 1296-304
10. Ohara N, Morikawa A, Chen W, et al. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells. Reprod Sci. 2007 ; 14 (8 suppl). 20-27
11. Levens ED, Potlog-Nahari C, Armstrong AY, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol. 2008 ; 111 (5). 1129-1136 (Pubitemid 351620347)
12. Xu Q, Takekida S, Ohara N, et al. Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells. J Clin Endocrinol Metab. 2005 ; 90 (2). 953-961 (Pubitemid 40279221)
13. Attardi BJ, Burgenson J, Hild SA, Reel JR, Blye RP. CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914. Mol Cell Endocrinol. 2002 ; 188 (1-2). 111-123 (Pubitemid 34242671)
14. Wiehle RB, Goldberg J, Brodniewicz T, Dziedzic KJ, Jabiry-Zieniewicz Z. Effects of a new progesterone receptor modulator, CDB-4124, on fibroid size and uterine bleeding. (US obstetrics and Gynecology). Touch Briefings. 2008 ; 3 (1). 17-20
15. Ioffe OB, Zaino RJ, Mutter GL. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator. Mod Pathol. 2009 ; 22 (3). 450-459
16. Malik M, Webb J, Catherino WH. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells. Clin Endocrinol (Oxf). 2008 ; 69 (3). 462-470
17. Malik M, Mendoza M, Payson M, Catherino W. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil Steril. 2009 ; 91 (5). 2177-2184
18. Couldwell WT, Hinton DR, He S, et al. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett. 1994 ; 345 (1). 43-46 (Pubitemid 24154662)
19. Jeyasuria P, Wetzel J, Bradley M, Subedi K, Condon J. Progesterone-regulated caspase 3 action in the mouse may play a role in uterine quiescence during pregnancy through fragmentation of uterine myocyte contractile proteins. Biol Reprod. 2009 ; 80 (5). 928-934
20. Wade H, Kobayashi S, Eaton M, et al. Multimodal regulation of E2F1 gene expression by progestins. Mol Cell Biol. 2010 ; 30 (8). 1866-1877
21. Malik M, Catherino WH. Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays. Fertil Steril. 2007 ; 87 (5). 116-172
22. Catherino WH, Malik M, Driggers P, Chappel S, Segars J, Davis J. Novel, orally active selective progesterone receptor modulator CP8947 inhibits leiomyoma cell proliferation without adversely affecting endometrium or myometrium. J Steroid Biochem Mol Biol. 2010 ; 122 (4). 279-286
23. Luo X, Yin P, Coon VJ, Cheng YH, Wiehle RD, Bulun SE. The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells. Fertil Steril. 2010 ; 93 (8). 2668-2673
24. Singh P, Krishna A. Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice. J Ovarian Res. 2010 ; 3: 26
25. Miura S, Khan KN, Kitajima M, et al. Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod. 2006 ; 21 (10). 2545-2554 (Pubitemid 44542145)
26. Rein MS, Powell WL, Walters FC, et al. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod. 1998 ; 4 (1). 83-86 (Pubitemid 28109165)
27. Lobel M, Somasundaram P, Morton C. The genetic heterogeneity of uterine leiomyomata. Obstet Gyneco Clin North Am. 2006 ; 33 (1). 13-39
28. Hodge J, Quade B, Rubin M. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids. Am J Pathol. 2008 ; 172 (5). 1403-1410 (Pubitemid 351671552)
29. Yin P, Lin Z, Cheng Y, et al. Progesterone receptor regulates Bcl-2 gene expression through direct binding to its promoter region in uterine leiomyoma cells. J Clin Endocrinol Metab. 2007 ; 92 (111). 4459-466 (Pubitemid 350074770)
30. Morikawa A, Ohara N, Xu Q, et al. Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer. Hum Reprod. 2008 ; 23 (4). 944-951
31. Xu Q, Ohara N, Liu J, et al. Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells. Mol Hum Reprod. 2008 ; 14 (3). 181-191 (Pubitemid 351404891)
32. Xu Q, Ohara N, Chen W, et al. Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. Hum Reprod. 2006 ; 21 (9). 2408-2416 (Pubitemid 44530620)